Post by PharmaShots

#SunshineLakePharma reports FDA approval for Langlara, an interchangeable biosimilar to Lantus, expanding access to affordable insulin for type 1 and type 2 diabetes patients through its partnership with Lannett Company, Inc. Subscribe to our weekly newsletter and never miss a beat: https://lnkd.in/gTU62Zbz #lannettcompany #sunshinelakepharma #usfda #approval #langlara #biosimilar #lantus https://lnkd.in/gG4nDXDe